.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Chubb
Boehringer Ingelheim
Fish and Richardson
US Army
Express Scripts
Novartis
Queensland Health
Cantor Fitzgerald
Harvard Business School

Generated: June 23, 2017

DrugPatentWatch Database Preview

LIDODERM Drug Profile

« Back to Dashboard

What is the patent landscape for Lidoderm, and what generic Lidoderm alternatives are available?

Lidoderm is a drug marketed by Teikoku Pharma Usa and is included in one NDA.

The generic ingredient in LIDODERM is lidocaine. There are twenty-nine drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the lidocaine profile page.

Summary for Tradename: LIDODERM

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list17
Bulk Api Vendors: see list71
Clinical Trials: see list14
Patent Applications: see list8,258
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LIDODERM at DailyMed

Pharmacology for Tradename: LIDODERM

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Antiarrhythmic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teikoku Pharma Usa
LIDODERM
lidocaine
PATCH;TOPICAL020612-001Mar 19, 1999ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LIDODERM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teikoku Pharma Usa
LIDODERM
lidocaine
PATCH;TOPICAL020612-001Mar 19, 19995,601,838► Subscribe
Teikoku Pharma Usa
LIDODERM
lidocaine
PATCH;TOPICAL020612-001Mar 19, 19995,741,510► Subscribe
Teikoku Pharma Usa
LIDODERM
lidocaine
PATCH;TOPICAL020612-001Mar 19, 19995,827,529► Subscribe
Teikoku Pharma Usa
LIDODERM
lidocaine
PATCH;TOPICAL020612-001Mar 19, 19995,411,738► Subscribe
Teikoku Pharma Usa
LIDODERM
lidocaine
PATCH;TOPICAL020612-001Mar 19, 19995,709,869► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: LIDODERM

Drugname Dosage Strength RLD Submissiondate
lidocaineTopical Patch5%Lidoderm11/13/2009
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
UBS
Argus Health
Johnson and Johnson
Boehringer Ingelheim
Chinese Patent Office
Mallinckrodt
Healthtrust
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot